A day after the Centre approved Biological E’s Corbevax as a precaution dose for those above 18 years fully vaccinated with either Covishield or Covaxin, the state health & family welfare (H&FW) department has informed that Corbevax was now available as heterologous precaution dose in 18+ cohort.
In a letter to the chief medical officers (Kohima, Dimapur, Mokokchung, Mon, Longieng, Tuensang, Kiphire, Peren, Phek, Wokha and Zunheboto), the state immunization officer, H&FW, Dr. Ritu Thurr, said that this would complement the ongoing “COVID Vaccination Amrit Mahotsav (from July 15, 2022 to September 30, 2022), to cover eligible beneficiaries above 18 years with precaution dose. The department has informed that Corbevax would be available as precaution dose after completion of 6 months or 26 weeks from the date of administration of the second dose of either Covaxin or Covishield vaccines for population above 18 years.
It said this enables use of Corbevax as a heterologous Covid-19 vaccines for precaution dose administration in this age group.
The department also stated that there would be no change in existing guidelines for homologous precaution dose administration of Covaxin and Covishield vaccine. In addition to the existing homologous precaution dose, the option of a heterologous precaution dose with Corbevax would be available to all persons above 18 years of age.
The department stated that all necessary changes in regard to the administration of heterologous precaution dose using Corbevax to those who were eligible and due for precaution dose have been made in the Co-WIN Portal, adding that this provision would be live from August 12, 2022.
CMOs have, therefore, been directed to extend the necessary services and administer Corbevax to all eligible beneficiaries.
State logs 4 fresh Covid cases: Nagaland Thursday recorded four fresh Covid-19 positive cases, taking the total caseload to 35,859. The State currently has 46 active cases after 13 more patients recovered from the infection.
